반응식
[Cl:1][C:2]1[CH:10]=[CH:9][C:8]([C:11]2[N:12](C(OC(C)(C)C)=O)[C:13]3[C:18]([CH:19]=2)=[CH:17][CH:16]=[CH:15][CH:14]=3)=[C:7]2[C:3]=1[CH2:4][NH:5][C:6]2=[O:27].Cl.CO>CO>[Cl:1][C:2]1[CH:10]=[CH:9][C:8]([C:11]2[NH:12][C:13]3[C:18]([CH:19]=2)=[CH:17][CH:16]=[CH:15][CH:14]=3)=[C:7]2[C:3]=1[CH2:4][NH:5][C:6]2=[O:27]참가 물질
4
실험 절차
In a similar manner to Step 3 of Example 1, 4-chloro-7-(1-(tert-butoxycarbonyl)indol-2-yl)isoindolinone (39.3 mg, 0.103 mmol) was dissolved in methanol (3.9 mL), and the solution was treated with 10% hydrogen chloride-methanol solution (3.9 mL), followed by purification by preparative thin-layer chromatography (chloroform/acetone=12/1) to obtain Compound 16 (24 mg, yield 83%).
후처리
- customfollowed by purification by preparative thin-layer chromatography (chloroform/acetone=12/1)
출처 및 근거
- ORD 기록
- ord-9b10dc33d0c54454ab18f041a0257c0f
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07745641B2
연결된 노트
불러오는 중…